ACADIA PHARMACEUTICALS INC (ACAD)

13F ownership of ACADIA PHARMACEUTICALS INC among the superinvestors tracked on fructus.finance, based on their latest quarterly SEC filings.

Price history

Loading...
Tracked holders
4
Combined value
$150M
New buyers this quarter
1

Superinvestors holding ACAD

S
Steven Cohen
Point72 Asset Management, L.P. · Q2 2026
$62M
0.07% of portfolio (-5.6%)
Trimmed
K
Ken Griffin
Citadel Advisors LLC · Q2 2026
$55M
0.01% of portfolio
New buy
J
Jim Simons
Renaissance Technologies LLC · Q2 2026
$32M
0.04% of portfolio (-25.6%)
Trimmed
R
Ray Dalio
Bridgewater Associates, LP · Q2 2026
$1M
0.01% of portfolio (-64.6%)
Trimmed

Based on 13F filings submitted to the SEC, published with roughly 45 days of lag. Only long equity positions are captured. See our guide on how to read a 13F filing for more context, or browse the full superinvestor consensus.